Latest Trends in Anti-HER2 Breast Cancer Therapies

Dear Dr. Renukaprasad A R, HER2 levels strongly correlate with carcinogenesis, making it an adverse prognostic marker. Although HER2 is an excellent target for breast cancer treatment, resistance to anti-HER2 drugs in the advanced stages of cancer remains a challenge. Several kinds of research are ongoing to determine the effectiveness of anti-HER2 treatment alone and in combination with other drugs for HER2-positive metastatic breast cancer. For more insights on the latest developments in anti-HER2 therapy for breast cancer, join the proficient oncologist, Dr. Uma Dangi, in an exclusive webinar, TODAY at 3:00 PM IST. Click to Join Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in�� |� +91 98500 36954 You are receiving this communication because you are registered member of Docplexus. Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*